Green Shoe Options

Green Shoe Options

In the ever-evolving landscape of finance and investment, it is crucial to stay informed about various financial instruments. One such instrument that has gained significant popularity is the Green Shoe option. Green Shoe options play a vital role in the IPO process, benefiting both issuing companies and underwriters. By providing flexibility and stabilising stock prices, Green Shoe options enhance investor confidence, reduce risks, and maintain market equilibrium. Understanding this financial term equips investors and businesses alike with valuable knowledge in navigating the ever-changing world of finance. 

What are green shoe options? 

Green shoe options, also known as over-allotment options, are provisions included in the underwriting agreement between an issuing company and its underwriter during an initial public offering, or IPO. These options grant the underwriter the right to issue additional shares to meet excess demand in the market. 

The name “green shoe” originated from the Green Shoe Manufacturing Company, which was the first company to utilise this mechanism in the 1960s. The US Securities and Exchange Commission, or SEC, later formalised the concept as a means to stabilise volatile IPO markets. 

Understanding green shoe options 

When a company decides to go public through an IPO, it partners with an underwriter who assists in the offering process. The underwriter’s role is to facilitate the sale of the company’s shares to investors. To mitigate the risk of under-pricing or oversubscription, the underwriter and the issuing company may include a green shoe option in the underwriting agreement. 

The green shoe option allows the underwriter to sell additional shares, usually up to 15% of the original offering, within a specified time frame, typically 30 days after the IPO. This option helps balance supply and demand, ensuring price stability and preventing extreme fluctuations in the stock’s value during its initial trading period. 

Green shoe options provide a mechanism to address excess demand during IPOs, contributing to market stability and optimising the offering process for both issuing companies and underwriters. 

Working of green shoe options 

Once the IPO is complete, the underwriter observes the stock’s performance in the market. If the demand for the stock exceeds the available supply, the underwriter exercises the green shoe option. This involves purchasing additional shares from the issuing company at the offering price and subsequently selling them to investors at the prevailing market price. 

By exercising the green shoe option, the underwriter increases the supply of shares, satisfying the excess demand. This helps prevent rapid price appreciation and ensures a more stable market for the newly listed stock. The additional proceeds generated from the sale of these additional shares are typically shared between the underwriter and the issuing company. 

Advantages of green shoe options 

  1. Price stabilisation: One of the primary advantages of green shoe options is their ability to stabilise the price of newly listed stocks. By providing the underwriter with the option to release additional shares, the demand-supply equilibrium is maintained, avoiding sudden price spikes or plunges.
  2. Mitigation of Risk: Green shoe options offer a level of protection to underwriters by allowing them to manage the risks associated with IPOs. The additional shares can be utilised to offset the risk of being caught in an oversubscribed or undersubscribed scenario.
  3. Enhanced Investor Confidence: Green shoe options instill confidence among investors by signalling that there is a mechanism in place to manage potential market volatility. This confidence can attract more investors to participate in IPOs.
  4. Flexibility for Issuers: For issuing companies, green shoe options provide flexibility in adjusting the number of shares available for purchase. If demand is high, the option can be exercised to meet this demand. Conversely, if demand is lower than anticipated, the option can be left unexercised, ensuring the issuing company does not have to issue more shares than necessary. 

Example of green shoe options 

Let’s consider a hypothetical example to better understand how green shoe options work. Company XYZ, an emerging technology firm, plans to go public through an IPO. The underwriter agrees to include a green shoe option in the underwriting agreement. 

Initially, Company XYZ offers 10 million shares at a price of US$10 per share, aiming to raise US$100 million. The underwriter exercises the green shoe option, allowing it to purchase an additional 1.5 million shares from Company XYZ. Subsequently, these shares are sold to interested investors in the market. 

If the market price rises to US$12 per share, the underwriter generates additional proceeds of US$3 million (US$12 per share – US$10 per share x 1.5 million shares). This additional revenue is divided between the underwriter and Company XYZ according to their pre-determined agreement. 

Frequently Asked Questions

In finance, a green shoe refers to the provision in an underwriting agreement that grants the underwriter the right to issue additional shares to meet excess demand during an IPO. 

In the business context, green shoe options allow underwriters to stabilise the price of newly listed stocks by selling additional shares to meet high demand or manage the risk of undersubscription. 

The concept of green shoe options involves granting the underwriter the right to purchase and sell additional shares to maintain price stability and address excess demand during an IPO. 

In company law, green shoe options pertain to the provisions included in an underwriting agreement that enable underwriters to issue additional shares during an IPO to stabilise stock prices. 

Related Terms

    Read the Latest Market Journal

    Weekly Updates 15/4/24 – 19/4/24

    Published on Apr 15, 2024 30 

    This weekly update is designed to help you stay informed and relate economic and company...

    From $50 to $100: Unveiling the Impact of Inflation

    Published on Apr 12, 2024 111 

    In recent years, inflation has become a hot topic, evoking strong emotions as the cost...

    Japan’s Economic Resurgence: Unveiling the Tailwinds Behind Nikkei 225’s Record Leap

    Published on Apr 11, 2024 71 

    Source: eSignal, Intercontinental Exchange, Inc. In the heart of Japan’s economic landscape, the Nikkei 225...

    Weekly Updates 8/4/24 – 12/4/24

    Published on Apr 8, 2024 103 

      This weekly update is designed to help you stay informed and relate economic and...

    What Makes Forex Trading Attractive?

    Published on Apr 2, 2024 183 

    In a world where the click of a button can send goods across oceans and...

    Weekly Updates 1/4/24 – 5/4/24

    Published on Apr 1, 2024 97 

    This weekly update is designed to help you stay informed and relate economic and company...

    How to soar higher with Positive Carry!

    Published on Mar 28, 2024 133 

    As US Fed interest rates are predicted to rise 6 times this year, it’s best...

    Why 2024 Offers A Small Window of Opportunity and How to Position Yourself to Capture It

    Published on Mar 28, 2024 183 

    With the Federal Reserve (FED) finally indicating rate cuts in 2024, we witnessed a significant...

    Contact us to Open an Account

    Need Assistance? Share your Details and we’ll get back to you


    This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

    An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

    Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

    Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

    The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <> for more information in relation to the dividend distributions.  

    The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

    The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

    This advertisement has not been reviewed by the Monetary Authority of Singapore.  


    Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
    250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
    Tel: (65) 6230 8133 Fax: (65) 65383066